return to news
  1. Entero Healthcare Solutions Limited IPO review | Entero Healthcare IPO on Upstox

Entero Healthcare Solutions Limited IPO review | Entero Healthcare IPO on Upstox

blog author image

Upstox

blog verification badge

2 min read • Updated: February 8, 2024, 6:36 PM

Facebook PageTwitter PageLinkedin Page

Summary

In this video, we're diving into the details of the Entero Healthcare Solutions Limited IPO, open for subscription from 9th to 13th February 2024. We'll explore all the essential aspects of this IPO, along with understanding Entero Healthcare Solutions Limited's business and its growth potential.

💼 Entero Healthcare Solutions IPO Details: The price band is set between ₹1,195 to ₹1,258 per share, with a lot size of 11 shares. The minimum investment required for a lot is ₹13,838, and the subscription closes on 13th February 2024. The IPO listing is scheduled for 16th February 2024.

🏥Entero Healthcare Solutions’ Business Established in 2018, Entero Healthcare Solutions is a distributor of healthcare products to pharmacies, hospitals, and clinics. By FY22, it ranked among India's top three healthcare product distributors, witnessing the fastest scale-up of operations in the industry between FY19 and FY22.

🌐Pan-India Distribution Platform With 77 warehouses across 19 states and UTs as of 30th September 2023, Entero Healthcare Solutions boasts a pan-India distribution platform. It serves over 73,700 retail customers and more than 2,800 hospital customers, ensuring competitive pricing and adequate inventory levels.

💉Benefits of Widespread Reach Entero Healthcare Solutions leverages its extensive reach to procure a wide range of healthcare products at competitive prices while maintaining optimal inventory levels. Additionally, it provides healthcare product manufacturers access to valuable client data, intelligence, and sales analytics.

💼Diverse Distribution Portfolio The company offers a diverse spectrum of healthcare products, including pharmaceuticals, nutraceuticals, medical devices, surgical consumables, and over-the-counter medicines.

💰Business Growth Entero Healthcare Solutions has been growing its business organically and inorganically, acquiring 34 companies in the healthcare products distribution industry since its inception.

📊Financial Performance The financial snapshot reveals significant revenue growth, with a 22% CAGR between FY21 and FY23. The company aims to capitalise on the projected 11-12% CAGR growth of the Indian healthcare market between FY23 and FY28.

📈 Objective of the IPO The IPO includes an offer for sale and a fresh issue. Proceeds from the fresh issue will be utilised for various purposes, including borrowings repayment, long-term working capital requirements, acquisitions, and general corporate purposes.